Introduction for Stem Cell-Based Therapy for Neurodegenerative Diseases.

Area of Science:

• Neuroscience
• Regenerative Medicine
• Stem Cell Biology

Background:

• Neurodegenerative diseases (NDs) involve progressive neuron loss in the brain and spinal cord.
• Current treatments lack efficacy in halting disease progression.
• Stem cell-based therapies offer potential therapeutic avenues for NDs.

Purpose of the Study:

• To review the potential of stem cell transplantation for treating neurodegenerative diseases.
• To highlight advancements in stem cell reprogramming and differentiation.
• To identify challenges hindering clinical translation of stem cell therapies.

Main Methods:

• Review of current literature on stem cell transplantation in neurodegenerative disease models.
• Analysis of induced pluripotent stem cells (iPS cells) and direct neural reprogramming.
• Examination of preclinical and early clinical trial data.

Main Results:

• Stem cell transplantation has shown efficacy in animal models by replacing neural cells, modulating inflammation, and promoting remyelination.
• Induced pluripotent stem cells can differentiate into various neural cell types, potentially avoiding immune rejection.
• Preclinical studies and some clinical trials demonstrate the effectiveness of transplanted stem cells.

Conclusions:

• Stem cell therapies hold significant potential for treating neurodegenerative diseases.
• Overcoming challenges in directed differentiation, migration, survival, and functional integration of transplanted cells is crucial.
• Further research into molecular mechanisms is necessary for successful clinical application.